Hiromi Muramatsu

Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability

Katalin Karikó, Hiromi Muramatsu, Frank A. Welsh et al. · Molecular Therapy · 2008 · 1.9K citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes

Norbert Pardi, Steven Tuyishime, Hiromi Muramatsu et al. · Journal of Controlled Release · 2015 · 1K citations

Pharmacy, Molecular Biology, Molecular Pharmaceutics +17

Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination

Norbert Pardi, Michael J. Hogan, Rebecca S. Pelc et al. · Nature · 2017 · 888 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA

Katalin Karikó, Hiromi Muramatsu, János Ludwig et al. · Nucleic Acids Research · 2011 · 884 citations · Full text

Life Sciences, Immunology, Molecular Biology +15

Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses

Mohamad‐Gabriel Alameh, István Tombácz, Emily Bettini et al. · Immunity · 2021 · 723 citations · Full text

Pharmacy, Immunology, Pharmaceutical Biotechnology +17